T4	Disorder 23 33	autoimmune
T10	Subject 1469 1477	patients
T11	Disorder 337 347	autoimmune
T12	Subject 892 900	patients
T13	Subject 1275 1283	patients
T15	Anatomical_entity 223 233	lower lobe
T20	Subject 1336 1344	patients
T24	Disorder 505 514	emphysema
T27	Artificial_process 630 639	treatment
T29	Anatomical_entity 641 646	serum
T33	Anatomical_entity 1262 1266	lung
T37	Subject 799 807	patients
T43	Subject 45 53	patients
T44	Disorder 1058 1068	autoimmune
T45	Cell 696 702	B cell
T48	Subject 1640 1648	patients
T53	Disorder 1002 1011	emphysema
T54	Subject 359 367	patients
T57	Anatomical_entity 1298 1303	serum
T59	Subject 976 984	patients
T60	Subject 1117 1125	patients
T64	Anatomical_entity 198 208	upper lobe
T71	Anatomical_entity 915 920	serum
T73	GGPs 731 735	CD20
T74	Subject 1026 1034	Patients
T75	Disorder 234 252	pulmonary fibrosis
T79	Disorder 990 993	IPF
T82	Disorder 209 218	emphysema
T92	Subject 456 464	patients
E6	Artificial_process:T27 
N29	Reference T10 UMLS:C0030705	Patients
N33	Reference T12 UMLS:C0030705	Patients
N35	Reference T13 UMLS:C0030705	Patients
N42	Reference T15 UMLS:C0225758	Structure of lower lobe of lung
N61	Reference T20 UMLS:C0030705	Patients
N78	Reference T24 UMLS:C0034067	Pulmonary Emphysema
N97	Reference E6 UMLS:C0087111	Therapeutic procedure
N107	Reference T29 UMLS:C0229671	Serum
N138	Reference T33 UMLS:C0024109	Lung
N150	Reference T37 UMLS:C0030705	Patients
N171	Reference T43 UMLS:C0030705	Patients
N176	Reference T45 UMLS:C0004561	B-Lymphocytes
N187	Reference T48 UMLS:C0030705	Patients
N201	Reference T53 UMLS:C0034067	Pulmonary Emphysema
N206	Reference T54 UMLS:C0030705	Patients
N221	Reference T57 UMLS:C0229671	Serum
N224	Reference T59 UMLS:C0030705	Patients
N226	Reference T60 UMLS:C0030705	Patients
N238	Reference T64 UMLS:C0225756	Structure of upper lobe of lung
N272	Reference T71 UMLS:C0229671	Serum
N284	Reference T74 UMLS:C0030705	Patients
N286	Reference T75 UMLS:C0034069	Pulmonary Fibrosis
N303	Reference T79 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N313	Reference T82 UMLS:C0034067	Pulmonary Emphysema
N347	Reference T92 UMLS:C0030705	Patients
T96	Method_cue 555 590	high-resolution computed tomography
N1	Reference T96 UMLS:C1512457	High Resolution Computed Tomography
T97	Disorder 59 100	combined pulmonary fibrosis and emphysema
T98	Disorder 1516 1537	auto-immune disorders
N9	Reference T98 UMLS:C0004364	Autoimmune Diseases
T2	Disorder 115 156	Combined pulmonary fibrosis and emphysema
T9	Disorder 158 162	CPFE
T99	Disorder 373 377	CPFE
T100	Disorder 470 474	CPFE
T101	Disorder 794 798	CPFE
T102	Disorder 887 891	CPFE
T103	Disorder 1270 1274	CPFE
T104	Disorder 1040 1044	CPFE
T105	Disorder 1483 1487	CPFE
T46	GGPs 921 924	ANA
N3	Reference T46 UMLS:C0003243	Antibodies, Antinuclear
T58	Cell 1200 1213	CD20+ B cells
T8	GGPs 1666 1681	auto-antibodies
N13	Reference T8 UMLS:C0004358	Autoantibodies
N15	Reference T73 UMLS:C0054946	CD20 Antigens
N11	Reference T58 UMLS:C1267890	Lymphocyte positive for CD20 antigen
T17	Subject 812 828	control subjects
N17	Reference T17 UMLS:C0009932	Control Groups
T47	Subject 976 984	patients
N21	Reference T47 UMLS:C0030705	Patients
T50	Subject 476 480	n=40
N23	Reference T50 UMLS:C0030705	Patients
T61	Subject 491 495	n=60
N25	Reference T61 UMLS:C0030705	Patients
R3	Subject_Disorder Arg1:T43 Arg2:T97	
R4	Subject_Disorder Arg1:T54 Arg2:T99	
R5	Subject_Disorder Arg1:T37 Arg2:T101	
R6	Subject_Disorder Arg1:T12 Arg2:T102	
R7	Subject_Disorder Arg1:T47 Arg2:T79	
R8	Subject_Disorder Arg1:T59 Arg2:T53	
R9	Subject_Disorder Arg1:T74 Arg2:T104	
R10	Subject_Disorder Arg1:T10 Arg2:T105	
R13	Subject_Disorder Arg1:T13 Arg2:T103	
T32	Positive_regulation 906 914	elevated
E3	Positive_regulation:T32 Theme:T46 atLoc:T71 disorder:T102
N20	Reference E3 UMLS:C1879547	Activation action
T66	Subject 456 464	patients
N28	Reference T66 UMLS:C0030705	Patients
T70	Disorder 486 489	IPF
N32	Reference T70 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
R1	Subject_Disorder Arg1:T92 Arg2:T100	
R2	Subject_Disorder Arg1:T66 Arg2:T70	
R11	member_of Arg1:T50 Arg2:T92	
R12	member_of Arg1:T61 Arg2:T66	
R14	Subject_Disorder Arg1:T66 Arg2:T24	
T80	Biological_process 258 270	pathogenesis
E11	Biological_process:T80 Theme:T2
N30	Reference E11 UMLS:C0699748	Pathogenesis
T78	Method_cue 592 596	HRCT
N34	Reference T78 UMLS:C1512457	High Resolution Computed Tomography
T93	Anatomical_entity 1223 1241	lymphoid follicles
N40	Reference T93 UMLS:C0229654	Lymphoid nodule
A1	Count_sbjct T50
A2	Count_sbjct T61
T3	Positive_regulation 1087 1095	improved
E1	Positive_regulation:T3 
N5	Reference E1 UMLS:C1879547	Activation action
T28	Positive_regulation 1409 1417	improved
E15	Positive_regulation:T28 
N8	Reference E15 UMLS:C1879547	Activation action
T16	GGPs 950 956	p-ANCA
N14	Reference T16 UMLS:C0134596	p-ANCA
T30	Localization 1172 1184	infiltration
E10	Localization:T30 Theme:T58 toLoc:T93
N45	Reference E10 UMLS:C1692321	Cellular infiltrate
R16	part_of Arg1:T93 Arg2:T33	
T22	Anatomical_entity 769 788	lung biopsy samples
T39	Correlation 1393 1403	correlated
E2	Correlation:T39 Theme:E10 Theme2:E15
N10	Reference E2 UMLS:C0332281	Associated with
T62	Method_cue 736 750	immunostaining
N26	Reference T62 UMLS:C0021044	Immunohistochemistry
N38	Reference T22 UMLS:C0586651	Specimen from lung obtained by biopsy
R18	part_of Arg1:T22 Arg2:T37	
T72	Biological_process 1253 1261	fibrotic
E4	Biological_process:T72 Theme:T33
N56	Reference E4 UMLS:C0016059	Fibrosis
R20	part_of Arg1:T33 Arg2:T13	
R19	part_of Arg1:T22 Arg2:T17	
N16	Reference T4 UMLS:C0004364	Autoimmune Diseases
N31	Reference T11 UMLS:C0004364	Autoimmune Diseases
N53	Reference T44 UMLS:C0004364	Autoimmune Diseases
R21	Subject_Disorder Arg1:T43 Arg2:T4	
R22	Subject_Disorder Arg1:T54 Arg2:T11	
R23	Subject_Disorder Arg1:T74 Arg2:T44	
T40	Method_cue 599 609	spirometry
N58	Reference T40 UMLS:C0037981	Spirometry
